Showing results (1171-1180 of 5,676) with videos related to

Sort By:
Pageof 568
Drug Design, Development and Therapy|March 13, 2024
A Window for Enhanced Oral Delivery of Therapeutics via Lipid NanoparticlesHilda Amekyeh, Rayan Sabra, Nashiru Billa
Drug Design, Development and Therapy|March 11, 2024
Integrated Network Pharmacology and in vivo Experimental Validation Approach to Explore the Potential Antioxidant Effects of Annao Pingchong Decoction in Intracerebral Hemorrhage RatsXuqing Zhou, Xu Wang, Jiaqi Li, et al.
Drug Design, Development and Therapy|March 11, 2024
Clinical Study of Flumazenil Antagonizing Remimazolam on Nausea and Vomiting After Gynecologic Day SurgeryYaxin Wei, Min Zhu, Yan Man, et al.
Drug Design, Development and Therapy|February 9, 2024
Berberine Nanoparticles with Enhanced in vitro Bioavailability: Characterization and Antimicrobial Activity [Retraction]
Drug Design, Development and Therapy|February 13, 2024
Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?Eleftherios Chatzimichail, Kristina Pfau, Zisis Gatzioufas, et al.
Drug Design, Development and Therapy|February 12, 2024
Remifentanil is Superior to Propofol for Treating Emergence Agitation in Adults After General AnesthesiaJun Li, Hongrui Zhu, Yu Wang, et al.
Drug Design, Development and Therapy|April 3, 2024
The Emerging Roles of Nanocarrier Drug Delivery System in Treatment of Intervertebral Disc Degeneration-Current Knowledge, Hot Spots, Challenges and Future PerspectivesYunxiang Hu, Rui Yang, Sanmao Liu, et al.
Drug Design, Development and Therapy|April 8, 2024
Exploring the Median Effective Dose of Ciprofol for Anesthesia Induction in Elderly Patients: Impact of Frailty on ED50Jingjing Yuan, Zenghui Liang, Muhoza Bertrand Geoffrey, et al.
Drug Design, Development and Therapy|April 2, 2024
Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen TreatmentDan Li, Na Sun, Li Xiang, et al.
Drug Design, Development and Therapy|February 22, 2024
Efficacy of Intravenous Administration of Esketamine in Preventing and Treating Rebound Pain After Thoracic Paravertebral Nerve Block: A Prospective Randomized, Double-Blind, Placebo-Controlled TrialXu Zeng, Xianjie Zhang, Wencai Jiang, et al.
Pageof 568